Hotline: 1800 102 2007
X
Search Business Opportunities
Oct, 11 2018

Lilly India enters the autoimmune segment with Olumiant

Olumiant will be available in India starting October 2018 in 4mg and 2mg dosage forms.

Eli Lilly and Company (India) Pvt. Ltd. (Lilly India) has announced the launch of Olumiant (baricitinib), marking the company’s entry into the autoimmune segment in India.

Olumiant (baricitinib) is a once-daily oral medication for the treatment of adults with moderate-to-severe active Rheumatoid Arthritis who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). Olumiant may be used as monotherapy or in combination with methotrexate.

Olumiant will be available in India starting October 2018 in 4mg and 2mg dosage forms. It is approved in more than 50 countries across the world.

Luca Visini, Managing Director, Eli Lilly and Company India, said, "Few days ahead of World Arthritis Day, Lilly India is excited to announce the introduction of its innovative therapy for patients living with Rheumatoid Arthritis. It is an announcement that builds on our heritage and commitment to India, a 25 years strong legacy of making life better and addressing the unmet needs of patients living with chronic diseases."

"People with Rheumatoid Arthritis continue to struggle with the debilitating effects of the disease, endure pain and do not achieve disease management goals. This can lead to long-term joint damage and even disability. Olumiant is an effective, advanced once-daily oral treatment option for people suffering from Rheumatoid Arthritis who have not responded well to conventional DMARDs. In clinical trials, Olumiant has proven efficacy and demonstrated rapid and significant improvement in patient-related outcomes such as pain, fatigue and joint stiffness," he added.

Comment
image
Related opportunities
  • Juices / Smoothies / Dairy parlors
    About Us: Cream shakes has begun after much afterthought about the..
    Locations looking for expansion Delhi
    Establishment year 2017
    Franchising Launch Date 2018
    Investment size Rs. 10lac - 20lac
    Space required 300
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • About Us: Delhi Paramedical & Management Institute, popularly known as DPMI..
    Locations looking for expansion Delhi
    Establishment year 1996
    Franchising Launch Date 2014
    Investment size Rs. 10lac - 20lac
    Space required 2000 - 3500 Sq.ft
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater Delhi Delhi
  • Quick Service Restaurants
    About Us: Greetings from USPFC!! USPFC has come a long way from..
    Locations looking for expansion Rajasthan
    Establishment year 2013
    Franchising Launch Date 2014
    Investment size Rs. 5lac - 10lac
    Space required 200
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater Jaipur Rajasthan
  • Tea and Coffee Chain
    Chaipatty Teafe Pvt. Ltd. is a unique and contemporary art-based..
    Locations looking for expansion Karnataka
    Establishment year 2010
    Franchising Launch Date 2014
    Investment size Rs. 10lac - 20lac
    Space required 300 sqft - 1500 sqft
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Bangalore Karnataka
Insta-Subscribe to
The Franchising World
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities